UNIVERSITY OF ALABAMA AT BIRMINGHAM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Effectiveness of a School-Based Hand Sanitizer Program on Reducing Asthma Exacerbations
Not Applicable
Completed
- Conditions
- Asthma
- Interventions
- Other: Active Hand Sanitizer
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2017-11-27
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 527
- Registration Number
- NCT00528814
- Locations
- 🇺🇸
University of Alabama at Birmingham, Lung Health Center, Birmingham, Alabama, United States
Dynasplint Therapy for Trismus in Head and Neck Cancer
Not Applicable
Completed
- Conditions
- Trismus
- Interventions
- Other: Tongue DepressorsDevice: Dynasplint Trismus System
- First Posted Date
- 2007-07-26
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 53
- Registration Number
- NCT00507208
- Locations
- 🇺🇸
UAB Department of Otolaryngology, Birmingham, Alabama, United States
Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
- First Posted Date
- 2007-05-25
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 300
- Registration Number
- NCT00478556
- Locations
- 🇺🇸
The Kirklin Clinic, Birmingham, Alabama, United States
Investigation of Macular Pigment Augmentation on Dark Adaptation
Phase 4
Terminated
- Conditions
- Age-Related Macular DegenerationAging
- Interventions
- Dietary Supplement: ZeaVision EyePromise RestoreDietary Supplement: Multivitamin
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2010-10-27
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 13
- Registration Number
- NCT00478439
- Locations
- 🇺🇸
UAB School of Optometry, Birmingham, Alabama, United States
Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM
Not Applicable
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: Omnipod Insulin Management System
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 14
- Registration Number
- NCT00476788
- Locations
- 🇺🇸
Children's Hospital, Birmingham, Alabama, United States
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Non-Small Cell Lung CancerVenous Thromboembolism
- Interventions
- Drug: Combination of Arixtra with chemotherapy
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 23
- Registration Number
- NCT00476216
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
Not Applicable
Completed
- Conditions
- Oropharyngeal CancerUpper Aerodigestive Tract NeoplasmsHypopharyngeal CancerHead and Neck Cancer
- Interventions
- Procedure: da Vinci® Robotic System
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2016-03-08
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 170
- Registration Number
- NCT00473564
- Locations
- 🇺🇸
University of Alabama at Birmingham Medical Center, Birmingham, Alabama, United States
Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bariatric Surgery Patients
Not Applicable
Completed
- Conditions
- ObesityPost-gastric Bypass
- Interventions
- Dietary Supplement: receive amino acid supplement
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 30
- Registration Number
- NCT00473356
- Locations
- 🇺🇸
UAB Kirklin Clinic, Birmingham, Alabama, United States
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
Not Applicable
Completed
- Conditions
- Overactive Bladder
- Interventions
- Drug: Extended Release Tolterodine LADrug: Intra Vaginal Estradiol Cream
- First Posted Date
- 2007-04-25
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 58
- Registration Number
- NCT00465894
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
Completed
- Conditions
- Fabry DiseaseProteinuria
- First Posted Date
- 2007-03-13
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 36
- Registration Number
- NCT00446862
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
© Copyright 2025. All Rights Reserved by MedPath